由愛思唯爾健康出版。ISSN: 1542 - 3565。《臨床胃腸病學(xué)與肝病》(CGH)的使命是為讀者提供臨床胃腸病學(xué)與肝病的廣泛主題，包括癌癥、炎癥性疾病、功能性胃腸疾病、營養(yǎng)、吸收和分泌方面的診斷、內(nèi)鏡、介入和治療進(jìn)展。這個(gè)同行評(píng)審的雜志包括原始文章和學(xué)術(shù)評(píng)論，目的是所有發(fā)表的文章將立即與胃腸病學(xué)和肝病學(xué)專業(yè)的實(shí)踐相關(guān)。除了同行評(píng)審的文章外，該雜志還邀請了一些重要的評(píng)論和文章，內(nèi)容涉及基于內(nèi)鏡/實(shí)踐的技術(shù)、衛(wèi)生保健政策和實(shí)踐管理。此外,《華爾街日報(bào)》“s?編碼角落?提供專業(yè)人士在胃腸道實(shí)踐常見的編碼和計(jì)費(fèi)問題的答案。多媒體產(chǎn)品包括圖像、視頻摘要和播客。CGH還提供更新和評(píng)論通過Facebook、Twitter、LinkedIn、其研究博客博客??AGA期刊。CGH在湯森路透(Thomson Reuters) 2015年期刊引文報(bào)告(Citation Reports)?收錄的78種胃腸病學(xué)和肝病類期刊中排名第七，影響因子為7.680。平均而言，作者在不到兩周的時(shí)間內(nèi)就能收到關(guān)于他們手稿的決定。CGH的錄取率為12%，并在全球20,300個(gè)個(gè)人和機(jī)構(gòu)中流通。

Published by Elsevier Health. ISSN: 1542-3565.The mission of Clinical Gastroenterology and Hepatology (CGH) is to provide readers with a broad spectrum of themes in clinical gastroenterology and hepatology, including the diagnostic, endoscopic, interventional, and therapeutic advances in cancer, inflammatory diseases, functional gastrointestinal disorders, nutrition, absorption, and secretion. This peer-reviewed journal includes original articles as well as scholarly reviews, with the goal that all articles published will be immediately relevant to practice of the specialties of gastroenterology and hepatology. In addition to peer-reviewed articles, the journal includes invited key reviews and articles on endoscopy/practice-based technology, health-care policy, and practice management. Additionally, the journal''s ?Coding Corner? offers professionals in GI practice answers to common coding and billing questions. Multimedia offerings include images, video abstracts, and podcasts. CGH also provides updates and commentary via Facebook, Twitter, LinkedIn, and its research blog ?The AGA Journals Blog?.CGH is ranked 7th out of 78 journals in the Gastroenterology and Hepatology category on the 2015 Journal Citation Reports?, published by Thomson Reuters, and has an Impact Factor of 7.680. On average, authors receive decisions on their manuscripts in less than two weeks. CGH has an acceptance rate of 12% and is circulated to 20,300 individuals and institutions worldwide.